-
1
-
-
0038011833
-
Evolving concepts of rheumatoid arthritis
-
GS Firestein 2003 Evolving concepts of rheumatoid arthritis Nature. 423 356 361
-
(2003)
Nature.
, vol.423
, pp. 356-361
-
-
Firestein, G.S.1
-
2
-
-
0025274640
-
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis
-
WP Arend JM Dayer 1990 Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis Arthritis Rheum. 33 305 315
-
(1990)
Arthritis Rheum.
, vol.33
, pp. 305-315
-
-
Arend, W.P.1
Dayer, J.M.2
-
3
-
-
0037261964
-
Anti-cytokines and cytokines in the treatment of rheumatoid arthritis
-
PC Taylor 2003 Anti-cytokines and cytokines in the treatment of rheumatoid arthritis Curr Pharm Des. 9 1095 1106
-
(2003)
Curr Pharm Des.
, vol.9
, pp. 1095-1106
-
-
Taylor, P.C.1
-
4
-
-
0028861236
-
Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis
-
WP Arend JM Dayer 1995 Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis Arthritis Rheum. 38 151 160
-
(1995)
Arthritis Rheum.
, vol.38
, pp. 151-160
-
-
Arend, W.P.1
Dayer, J.M.2
-
6
-
-
0345490916
-
Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: A brief report and literature review
-
C Keller A Webb J Davis 2003 Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature review Ann Rheum Dis. 62 1128 1132
-
(2003)
Ann Rheum Dis.
, vol.62
, pp. 1128-1132
-
-
Keller, C.1
Webb, A.2
Davis, J.3
-
7
-
-
21044440292
-
Inflammatory mediators as potential therapeutic targets in the spine
-
S Roberts RC Butler 2005 Inflammatory mediators as potential therapeutic targets in the spine Curr Drug Targets Inflamm Allergy. 4 257 266
-
(2005)
Curr Drug Targets Inflamm Allergy.
, vol.4
, pp. 257-266
-
-
Roberts, S.1
Butler, R.C.2
-
8
-
-
17444394445
-
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
-
B Bresnihan JM Varo-Gracia M Cobby M Doherty Z Domljan P Emery G Nuki K Pavelka R Rau B Rozman I Watt B Williams R Aitchison D McCabe P Musikic 1998 Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist Arthritis Rheum. 41 2196 204
-
(1998)
Arthritis Rheum.
, vol.41
, pp. 2196-204
-
-
Bresnihan, B.1
Varo-Gracia, J.M.2
Cobby, M.3
Doherty, M.4
Domljan, Z.5
Emery, P.6
Nuki, G.7
Pavelka, K.8
Rau, R.9
Rozman, B.10
Watt, I.11
Williams, B.12
Aitchison, R.13
McCabe, D.14
Musikic, P.15
-
9
-
-
0034785930
-
Tumour necrosis factor-alpha blockers in rheumatoid arthritis: Review of the clinical experience
-
C Richard-Miceli M Dougados 2001 Tumour necrosis factor-alpha blockers in rheumatoid arthritis: review of the clinical experience BioDrugs. 15 251 259
-
(2001)
BioDrugs.
, vol.15
, pp. 251-259
-
-
Richard-Miceli, C.1
Dougados, M.2
-
10
-
-
0036822909
-
Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis
-
A Coxon B Bolon J Estrada S Kaufman S Scully A Rattan 2002 Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis Arthritis Rheum. 46 2604 2612
-
(2002)
Arthritis Rheum.
, vol.46
, pp. 2604-2612
-
-
Coxon, A.1
Bolon, B.2
Estrada, J.3
Kaufman, S.4
Scully, S.5
Rattan, A.6
-
11
-
-
0033769803
-
Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis rats
-
U Feige YL Hu J Gasser G Campagnuolo L Munyakazi B Bolon 2000 Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis rats Cell Mol Life Sci. 57 1457 1470
-
(2000)
Cell Mol Life Sci.
, vol.57
, pp. 1457-1470
-
-
Feige, U.1
Hu, Y.L.2
Gasser, J.3
Campagnuolo, G.4
Munyakazi, L.5
Bolon, B.6
-
12
-
-
0032752705
-
IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation
-
LA Joosten MM Helsen T Saxne FA van de Loo D Heinegard WB van den Berg 1999 IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation J Immunol. 163 5049 5055
-
(1999)
J Immunol.
, vol.163
, pp. 5049-5055
-
-
Joosten, L.A.1
Helsen, M.M.2
Saxne, T.3
Van De Loo, F.A.4
Heinegard, D.5
Van Den Berg, W.B.6
-
14
-
-
0027422060
-
Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice
-
PH Wooley J Dutcher MB Widmer S Gillis 1993 Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice J Immunol. 151 6602 6607
-
(1993)
J Immunol.
, vol.151
, pp. 6602-6607
-
-
Wooley, P.H.1
Dutcher, J.2
Widmer, M.B.3
Gillis, S.4
-
15
-
-
0027371372
-
The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice
-
PH Wooley JD Whalen DL Chapman AE Berger KA Richard DG Aspar 1993 The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice Arthritis Rheum. 36 1305 1314
-
(1993)
Arthritis Rheum.
, vol.36
, pp. 1305-1314
-
-
Wooley, P.H.1
Whalen, J.D.2
Chapman, D.L.3
Berger, A.E.4
Richard, K.A.5
Aspar, D.G.6
-
16
-
-
0032742629
-
Future trends in the treatment of rheumatoid arthritis: Cytokine targets
-
Suppl 2
-
FC Breedveld 1999 Future trends in the treatment of rheumatoid arthritis: cytokine targets Rheumatology (Oxford). 38 Suppl 2 11 13
-
(1999)
Rheumatology (Oxford).
, vol.38
, pp. 11-13
-
-
Breedveld, F.C.1
-
17
-
-
0037366864
-
Molecular differences in anticytokine therapies
-
LH Calabrese 2003 Molecular differences in anticytokine therapies Clin Exp Rheumatol. 21 241 248
-
(2003)
Clin Exp Rheumatol.
, vol.21
, pp. 241-248
-
-
Calabrese, L.H.1
-
20
-
-
2542465896
-
Interleukin-1beta and tumor necrosis factor-alpha produce distinct, time-dependent patterns of acute arthritis in the rat knee
-
B Bolon G Campagnuolo L Zhu D Duryea D Zack U Feige 2004 Interleukin-1beta and tumor necrosis factor-alpha produce distinct, time-dependent patterns of acute arthritis in the rat knee Vet Pathol. 41 235 243
-
(2004)
Vet Pathol.
, vol.41
, pp. 235-243
-
-
Bolon, B.1
Campagnuolo, G.2
Zhu, L.3
Duryea, D.4
Zack, D.5
Feige, U.6
-
21
-
-
0029875804
-
Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. a comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra
-
LA Joosten MM Helsen FA van de Loo WB van den Berg 1996 Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra Arthritis Rheum. 39 797 809
-
(1996)
Arthritis Rheum.
, vol.39
, pp. 797-809
-
-
Joosten, L.A.1
Helsen, M.M.2
Van De Loo, F.A.3
Van Den Berg, W.B.4
-
23
-
-
0036068297
-
Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis
-
G Campagnuolo B Bolon U Feige 2002 Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis Arthritis Rheum. 46 1926 1936
-
(2002)
Arthritis Rheum.
, vol.46
, pp. 1926-1936
-
-
Campagnuolo, G.1
Bolon, B.2
Feige, U.3
-
24
-
-
20844434038
-
Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models
-
G Schett S Middleton B Bolon M Stolina H Brown L Zhu 2005 Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models Arthritis Rheum. 52 1604 1611
-
(2005)
Arthritis Rheum.
, vol.52
, pp. 1604-1611
-
-
Schett, G.1
Middleton, S.2
Bolon, B.3
Stolina, M.4
Brown, H.5
Zhu, L.6
-
25
-
-
8544277272
-
Biology of recently discovered cytokines: Interleukin-17-a unique inflammatory cytokine with roles in bone biology and arthritis
-
SL Gaffen 2004 Biology of recently discovered cytokines: interleukin-17-a unique inflammatory cytokine with roles in bone biology and arthritis Arthritis Res Ther. 6 240 247
-
(2004)
Arthritis Res Ther.
, vol.6
, pp. 240-247
-
-
Gaffen, S.L.1
-
26
-
-
13444251815
-
Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis
-
IB McInnes JA Gracie 2004 Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis Curr Rheumatol Rep. 6 336 342
-
(2004)
Curr Rheumatol Rep.
, vol.6
, pp. 336-342
-
-
McInnes, I.B.1
Gracie, J.A.2
-
27
-
-
0030140458
-
Monocyte chemoattractant protein 1: A potential regulator of monocyte recruitment in inflammatory disease
-
BJ Rollins 1996 Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease Mol Med Today. 2 198 204
-
(1996)
Mol Med Today.
, vol.2
, pp. 198-204
-
-
Rollins, B.J.1
-
28
-
-
0036191960
-
Clinical significance of cytokine determination in synovial fluid
-
L Punzi L Calo M Plebani 2002 Clinical significance of cytokine determination in synovial fluid Crit Rev Clin Lab Sci. 39 63 88
-
(2002)
Crit Rev Clin Lab Sci.
, vol.39
, pp. 63-88
-
-
Punzi, L.1
Calo, L.2
Plebani, M.3
-
29
-
-
32544444493
-
Targeted therapy in rheumatoid arthritis
-
MD Koller 2006 Targeted therapy in rheumatoid arthritis Wien Med Wochenschr. 156 53 60
-
(2006)
Wien Med Wochenschr.
, vol.156
, pp. 53-60
-
-
Koller, M.D.1
-
30
-
-
34447638865
-
Drug disease interactions: Role of inflammatory mediators in disease and variability in drug response
-
KM Kulmatycki F Jamali 2005 Drug disease interactions: role of inflammatory mediators in disease and variability in drug response J Pharm Pharmaceut Sci. 8 602 625
-
(2005)
J Pharm Pharmaceut Sci.
, vol.8
, pp. 602-625
-
-
Kulmatycki, K.M.1
Jamali, F.2
-
31
-
-
28944454010
-
Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis
-
IB McInnes JA Gracie 2005 Targeting cytokines beyond tumor necrosis factor-alpha and interleukin-1 in rheumatoid arthritis Curr Pain Headache Rep. 9 405 411
-
(2005)
Curr Pain Headache Rep.
, vol.9
, pp. 405-411
-
-
McInnes, I.B.1
Gracie, J.A.2
-
32
-
-
0036898425
-
Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis
-
B Bolon V Shalhoub PJ Kostenuik G Campagnuolo S Morony WJ Boyle 2002 Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis Arthritis Rheum. 46 3121 3135
-
(2002)
Arthritis Rheum.
, vol.46
, pp. 3121-3135
-
-
Bolon, B.1
Shalhoub, V.2
Kostenuik, P.J.3
Campagnuolo, G.4
Morony, S.5
Boyle, W.J.6
-
33
-
-
0036892685
-
Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: Semiquantitative and quantitative analysis
-
TN Crotti MD Smith H Weedon MJ Ahern DM Findlay M Kraan 2002 Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis Ann Rheum Dis. 61 1047 1054
-
(2002)
Ann Rheum Dis.
, vol.61
, pp. 1047-1054
-
-
Crotti, T.N.1
Smith, M.D.2
Weedon, H.3
Ahern, M.J.4
Findlay, D.M.5
Kraan, M.6
-
34
-
-
0033581952
-
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
-
YY Kong U Feige I Sarosi B Bolon A Tafuri S Morony 1999 Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand Nature. 402 304 309
-
(1999)
Nature.
, vol.402
, pp. 304-309
-
-
Kong, Y.Y.1
Feige, U.2
Sarosi, I.3
Bolon, B.4
Tafuri, A.5
Morony, S.6
-
35
-
-
0035153246
-
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis
-
AR Pettit H Ji SD von R Muller SR Goldring Y Choi C Benoist EM Gravallese 2001 TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis Am J Pathol. 159 1689 1699
-
(2001)
Am J Pathol.
, vol.159
, pp. 1689-1699
-
-
Pettit, A.R.1
Ji, H.2
Von, S.D.3
Muller, R.4
Goldring, S.R.5
Choi, Y.6
Benoist, C.7
Gravallese, E.M.8
-
36
-
-
0036792512
-
Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis
-
E Romas NA Sims DK Hards M Lindsay JW Quinn PF Ryan 2002 Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis Am J Pathol. 161 1419 1427
-
(2002)
Am J Pathol.
, vol.161
, pp. 1419-1427
-
-
Romas, E.1
Sims, N.A.2
Hards, D.K.3
Lindsay, M.4
Quinn, J.W.5
Ryan, P.F.6
-
37
-
-
0036185343
-
Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin
-
K Redlich S Hayer A Maier CR Dunstan M Tohidast-Akrad S Lang 2002 Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin Arthritis Rheum. 46 785 792
-
(2002)
Arthritis Rheum.
, vol.46
, pp. 785-792
-
-
Redlich, K.1
Hayer, S.2
Maier, A.3
Dunstan, C.R.4
Tohidast-Akrad, M.5
Lang, S.6
-
39
-
-
43949139580
-
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial
-
SB Cohen RK Dore NE Lane PA Ory CG Peterfy JT Sharp HD van der L Zhou W Tsuji R Newmark 2008 Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial Arthritis Rheum. 58 1299 1309
-
(2008)
Arthritis Rheum.
, vol.58
, pp. 1299-1309
-
-
Cohen, S.B.1
Dore, R.K.2
Lane, N.E.3
Ory, P.A.4
Peterfy, C.G.5
Sharp, J.T.6
Van Der, H.D.7
Zhou, L.8
Tsuji, W.9
Newmark, R.10
-
41
-
-
0035068522
-
Physiology of cytokine pathways in rheumatoid arthritis
-
WP Arend 2001 Physiology of cytokine pathways in rheumatoid arthritis Arthritis Rheum. 45 101 106
-
(2001)
Arthritis Rheum.
, vol.45
, pp. 101-106
-
-
Arend, W.P.1
-
42
-
-
24644434101
-
RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis
-
M Stolina S Adamu M Ominsky D Dwyer F Asuncion Z Geng 2005 RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis J Bone Miner Res. 20 1756 1765
-
(2005)
J Bone Miner Res.
, vol.20
, pp. 1756-1765
-
-
Stolina, M.1
Adamu, S.2
Ominsky, M.3
Dwyer, D.4
Asuncion, F.5
Geng, Z.6
-
43
-
-
0345688643
-
Measurement of inflammatory biomarkers in synovial tissue extracts by enzyme-linked immunosorbent assay
-
S Rosengren GS Firestein DL Boyle 2003 Measurement of inflammatory biomarkers in synovial tissue extracts by enzyme-linked immunosorbent assay Clin Diagn Lab Immunol. 10 1002 1010
-
(2003)
Clin Diagn Lab Immunol.
, vol.10
, pp. 1002-1010
-
-
Rosengren, S.1
Firestein, G.S.2
Boyle, D.L.3
-
45
-
-
0036710615
-
Duration of bone protection by a single osteoprotegerin injection in rats with adjuvant-induced arthritis
-
B Bolon G Campagnuolo U Feige 2002 Duration of bone protection by a single osteoprotegerin injection in rats with adjuvant-induced arthritis Cell Mol Life Sci. 59 1569 1576
-
(2002)
Cell Mol Life Sci.
, vol.59
, pp. 1569-1576
-
-
Bolon, B.1
Campagnuolo, G.2
Feige, U.3
-
46
-
-
0742304737
-
Osteoclast numbers in Lewis rats with adjuvant-induced arthritis: Identification of preferred sites and parameters for rapid quantitative analysis
-
B Bolon S Morony Y Cheng YL Hu U Feige 2004 Osteoclast numbers in Lewis rats with adjuvant-induced arthritis: identification of preferred sites and parameters for rapid quantitative analysis Vet Pathol. 41 30 36
-
(2004)
Vet Pathol.
, vol.41
, pp. 30-36
-
-
Bolon, B.1
Morony, S.2
Cheng, Y.3
Hu, Y.L.4
Feige, U.5
-
47
-
-
84891456522
-
-
2 Springer New York City
-
Targan SR, Shanahan F, Karp LC. Inflammatory bowel disease: from bench to bedside. 2nd ed. New York City: Springer; 2005.
-
(2005)
-
-
Targan, S.R.1
Shanahan, F.2
Karp, L.C.3
-
48
-
-
61849181836
-
-
2 Davis Philadelphia
-
Harmening DM. Clinical hematology and fundamentals of homeostasis. 2nd ed. Philadelphia: Davis; 1991.
-
(1991)
-
-
Harmening, D.M.1
-
50
-
-
0030832150
-
Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses
-
AM Oliver F Martin GL Gartland RH Carter JF Kearney 1997 Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses Eur J Immunol. 27 2366 2374
-
(1997)
Eur J Immunol.
, vol.27
, pp. 2366-2374
-
-
Oliver, A.M.1
Martin, F.2
Gartland, G.L.3
Carter, R.H.4
Kearney, J.F.5
-
51
-
-
2342424208
-
Application of acute phase protein measurements in veterinary clinical chemistry
-
HH Petersen JP Nielsen PM Heegaard 2004 Application of acute phase protein measurements in veterinary clinical chemistry Vet Res. 35 163 187
-
(2004)
Vet Res.
, vol.35
, pp. 163-187
-
-
Petersen, H.H.1
Nielsen, J.P.2
Heegaard, P.M.3
-
52
-
-
1942531962
-
An update on the cytokine network in rheumatoid arthritis
-
P Miossec 2004 An update on the cytokine network in rheumatoid arthritis Curr Opin Rheumatol. 16 218 222
-
(2004)
Curr Opin Rheumatol.
, vol.16
, pp. 218-222
-
-
Miossec, P.1
-
54
-
-
0032705588
-
Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis
-
Suppl 1
-
RN Maini PC Taylor E Paleolog P Charles S Ballara FM Brennan 1999 Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis Ann Rheum Dis. 58 Suppl 1 I56 60
-
(1999)
Ann Rheum Dis.
, vol.58
, pp. 56-60
-
-
Maini, R.N.1
Taylor, P.C.2
Paleolog, E.3
Charles, P.4
Ballara, S.5
Brennan, F.M.6
-
55
-
-
13444256307
-
The role of T-cell interleukin-17 in conducting destructive arthritis: Lessons from animal models
-
E Lubberts MI Koenders WB van den Berg 2005 The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models Arthritis Res Ther. 7 29 37
-
(2005)
Arthritis Res Ther.
, vol.7
, pp. 29-37
-
-
Lubberts, E.1
Koenders, M.I.2
Van Den Berg, W.B.3
-
57
-
-
0031787636
-
Joint inflammation and cartilage destruction may occur uncoupled
-
WB van den Berg 1998 Joint inflammation and cartilage destruction may occur uncoupled Springer Semin Immunopathol. 20 149 164
-
(1998)
Springer Semin Immunopathol.
, vol.20
, pp. 149-164
-
-
Van Den Berg, W.B.1
-
58
-
-
1642526641
-
RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis
-
P Li EM Schwarz RJ O'Keefe L Ma BF Boyce L Xing 2004 RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis J Bone Miner Res. 19 207 213
-
(2004)
J Bone Miner Res.
, vol.19
, pp. 207-213
-
-
Li, P.1
Schwarz, E.M.2
O'Keefe, R.J.3
Ma, L.4
Boyce, B.F.5
Xing, L.6
-
60
-
-
0037333960
-
Interleukin-17 in rheumatoid arthritis: If T cells were to contribute to inflammation and destruction through synergy
-
P Miossec 2003 Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy Arthritis Rheum. 48 594 601
-
(2003)
Arthritis Rheum.
, vol.48
, pp. 594-601
-
-
Miossec, P.1
-
61
-
-
33846966636
-
A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage
-
L Steinman 2007 A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage Nat Med. 13 139 145
-
(2007)
Nat Med.
, vol.13
, pp. 139-145
-
-
Steinman, L.1
-
62
-
-
0036232879
-
Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-beta1 in synovial fibroblasts from rheumatoid arthritis and normal individuals
-
H Cheon SJ Yu DH Yoo IJ Chae GG Song J Sohn 2002 Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-beta1 in synovial fibroblasts from rheumatoid arthritis and normal individuals Clin Exp Immunol. 127 547 552
-
(2002)
Clin Exp Immunol.
, vol.127
, pp. 547-552
-
-
Cheon, H.1
Yu, S.J.2
Yoo, D.H.3
Chae, I.J.4
Song, G.G.5
Sohn, J.6
-
63
-
-
0036232876
-
Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis
-
A Kehlen K Thiele D Riemann J Langner 2002 Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis Clin Exp Immunol. 127 539 546
-
(2002)
Clin Exp Immunol.
, vol.127
, pp. 539-546
-
-
Kehlen, A.1
Thiele, K.2
Riemann, D.3
Langner, J.4
-
64
-
-
0037300296
-
Chemokines and chemokine receptors in rheumatoid arthritis
-
Z Szekanecz J Kim AE Koch 2003 Chemokines and chemokine receptors in rheumatoid arthritis Semin Immunol. 15 15 21
-
(2003)
Semin Immunol.
, vol.15
, pp. 15-21
-
-
Szekanecz, Z.1
Kim, J.2
Koch, A.E.3
-
65
-
-
0034983630
-
Cytokines in bone and cartilage destruction and repair
-
W van den Berg 2001 Cytokines in bone and cartilage destruction and repair J Clin Rheumatol. 7 S8 11
-
(2001)
J Clin Rheumatol.
, vol.7
, pp. 8-11
-
-
Van Den Berg, W.1
-
66
-
-
47249127322
-
Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease-modifying antirheumatic drug treatment and correlation with radiologic outcome
-
D Haynes T Crotti H Weedon J Slavotinek V Au M Coleman 2008 Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease-modifying antirheumatic drug treatment and correlation with radiologic outcome Arthritis Rheum. 59 911 920
-
(2008)
Arthritis Rheum.
, vol.59
, pp. 911-920
-
-
Haynes, D.1
Crotti, T.2
Weedon, H.3
Slavotinek, J.4
Au, V.5
Coleman, M.6
-
67
-
-
27444441016
-
Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. a comparison of patients with longstanding rheumatoid arthritis and osteoarthritis
-
M Skoumal G Kolarz G Haberhauer W Woloszczuk G Hawa A Klingler 2005 Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritis Rheumatol Int. 26 63 69
-
(2005)
Rheumatol Int.
, vol.26
, pp. 63-69
-
-
Skoumal, M.1
Kolarz, G.2
Haberhauer, G.3
Woloszczuk, W.4
Hawa, G.5
Klingler, A.6
-
68
-
-
33745030280
-
The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction
-
PP Geusens R Landewe P Garnero D Chen CR Dunstan WF Lems 2006 The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction Arthritis Rheum. 54 1772 1777
-
(2006)
Arthritis Rheum.
, vol.54
, pp. 1772-1777
-
-
Geusens, P.P.1
Landewe, R.2
Garnero, P.3
Chen, D.4
Dunstan, C.R.5
Lems, W.F.6
-
69
-
-
33144480718
-
Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts
-
L Kindle L Rothe M Kriss P Osdoby P Collin-Osdoby 2006 Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts J Bone Miner Res. 21 193 206
-
(2006)
J Bone Miner Res.
, vol.21
, pp. 193-206
-
-
Kindle, L.1
Rothe, L.2
Kriss, M.3
Osdoby, P.4
Collin-Osdoby, P.5
-
70
-
-
0034523328
-
TNF-a induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand
-
J Lam S Takeshita JE Barker O Kanagawa FP Ross SL Teitelbaum 2000 TNF-a induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand J Clin Invest. 106 1481 1488
-
(2000)
J Clin Invest.
, vol.106
, pp. 1481-1488
-
-
Lam, J.1
Takeshita, S.2
Barker, J.E.3
Kanagawa, O.4
Ross, F.P.5
Teitelbaum, S.L.6
-
72
-
-
0032588998
-
Interleukin-1b and tumor necrosis factor-a, but not interleukin 6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells
-
LC Hofbauer DL Lacey CR Dunstan TC Spelsberg BL Riggs S Khosla 1999 Interleukin-1b and tumor necrosis factor-a, but not interleukin 6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells Bone. 25 255 259
-
(1999)
Bone.
, vol.25
, pp. 255-259
-
-
Hofbauer, L.C.1
Lacey, D.L.2
Dunstan, C.R.3
Spelsberg, T.C.4
Riggs, B.L.5
Khosla, S.6
-
73
-
-
21244482587
-
Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1
-
MI Koenders E Lubberts B Oppers-Walgreen L van den Bersselaar MM Helsen F Di Padova 2005 Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1 Am J Pathol. 167 141 149
-
(2005)
Am J Pathol.
, vol.167
, pp. 141-149
-
-
Koenders, M.I.1
Lubberts, E.2
Oppers-Walgreen, B.3
Van Den Bersselaar, L.4
Helsen, M.M.5
Di Padova, F.6
-
75
-
-
34249720998
-
Cytokines in the pathogenesis of rheumatoid arthritis
-
IB McInnes G Schett 2007 Cytokines in the pathogenesis of rheumatoid arthritis Nat Rev Immunol. 7 429 442
-
(2007)
Nat Rev Immunol.
, vol.7
, pp. 429-442
-
-
McInnes, I.B.1
Schett, G.2
|